Advancing CAR-T Development With NanoFCM: Characterising Viral and Non-Viral Delivery Systems:

As CAR-T therapies continue to evolve, both viral and non-viral delivery systems are emerging as powerful platforms for nucleic acid delivery and cellular engineering.  However, the successful development, optimisation, and translation of these complex delivery systems depends heavily on access to precise, high-resolution analytical technologies. In this webinar, we will demonstrate how nano-flow cytometry (NanoFCM) has become an essential tool for the characterisation of both viral vectors and non-viral nanoparticles, delivering critical single-particle insights that conventional techniques often cannot achieve.  Attendees will learn how NanoFCM enables accurate measurement of particle size, concentration, purity, cargo encapsulation efficiency, and ligand quantification at the single-particle level. These capabilities support process control, enhanced reproducibility, and accelerated development of next-generation CAR-T therapies.  Through real-world applications, we will showcase the growing role of NanoFCM as a foundational analytical platform for advanced cell and gene therapy workflows.